The FDA announced that it granted two additional approvals to Syneron Medical Ltd. and its North American subsidiary, Syneron Inc., for the company's hair removal and skin rejuvenation devices.
A Spotlight on SCIN: A New Tool From Google and Researchers at Stanford Medicine
ReV Up Your Vitiligo Treatment Strategies
Pointers With Portela: Providing Free Dermatologic Care
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 Therapy
Allergan Aesthetics Launches New Book to Bring More Awareness to Ethics in Aesthetics